TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 391625

Group type: EXPERIMENTAL
Intervention: Fixed combination of oxprenolol 80 mg + chlorthalidone 10 mg given once daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Fixed combination of oxprenolol 80 mg + chlorthalidone 10 mg given b.i.d.
Number of subjects: 40
Study: 31610616

Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg oral, 1 hour preprocedure
Number of subjects: 26
Study: 30298469

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus cisplatin (GC) as first-line chemotherapy
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Validation dataset of patients receiving GC therapy
Number of subjects: 307
Study: 28715589

Group type: EXPERIMENTAL
Intervention: Intravitreal sirolimus 44 μg
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Intravitreal sirolimus 440 μg
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Intravitreal sirolimus 880 μg
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Overall VFR
Number of subjects: 347
Study: 25762863

Group type: EXPERIMENTAL
Intervention: Resistance training plus diet (RT + diet)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Diet control group
Number of subjects: 7
Study: 23201174

Group type: EXPERIMENTAL
Intervention: varenicline 2mg
Number of subjects: 38

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 38
Study: 21508083

Group type: COMPARATOR
Intervention: Neutral position technique (group A, n=17)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Hyperextended internal rotation technique (group B, n=18)
Number of subjects: 35
Study: 18431091

Group type: EXPERIMENTAL
Intervention: Ergocalciferol 50,000 IU once weekly for 3 months
Number of subjects: 184

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 184
Study: 16567343

Group type: EXPERIMENTAL
Intervention: Propofol-remifentanil (PR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol-alfentanil (PA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Quality of wake-up test
Number of subjects: 60
Study: 14681961

Group type: EXPERIMENTAL
Intervention: Pronoran (piribedil) combined with levodopa, dosage 50-150 mg daily for 6 months
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 11065032

Group type: EXPERIMENTAL
Intervention: Birthing centre care
Number of subjects: 201

Group type: COMPARATOR
Intervention: Delivery suite care
Number of subjects: 201
Study: 1942321

Group type: EXPERIMENTAL
Intervention: Dietary advice to increase hydration (group 1, 57 patients)
Number of subjects: 140

Group type: COMPARATOR
Intervention: No dietary advice (group 2, 83 patients)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Use of urine specific gravity dipsticks (24 patients)
Number of subjects: 140
Study: 7029740

Group type: EXPERIMENTAL
Intervention: Fixed combination of metoprolol tartrate 100 mg and chlorthalidone 25 mg
Number of subjects: 71
Study: 31993665

Group type: EXPERIMENTAL
Intervention: Overnight sleep deprivation (complete nighttime wakefulness)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Nighttime sleep (10 pm to 6 am)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Overnight sleep deprivation
Number of subjects: 35
Study: 30937656

Group type: EXPERIMENTAL
Intervention: Taxane plus anthracycline (TA)
Number of subjects: 640

Group type: COMPARATOR
Intervention: Taxane plus anthracycline plus cyclophosphamide (TAC)
Number of subjects: 640
Study: 30030413

Group type: EXPERIMENTAL
Intervention: Lente insulin
Number of subjects: 30

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 30
Study: 26999053

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 1287

Group type: EXPERIMENTAL
Intervention: Women
Number of subjects: 1287

Group type: EXPERIMENTAL
Intervention: Men and Women
Number of subjects: 1287
Study: 24942594

Group type: EXPERIMENTAL
Intervention: 0.2% E6005 ointment
Number of subjects: 78

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 78
Study: 22201654

Group type: EXPERIMENTAL
Intervention: Coaching
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Standardized education
Number of subjects: 318

Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 318
Study: 20107767

Group type: EXPERIMENTAL
Intervention: Pelvic organ prolapse quantification (POP-Q) assessment by physiotherapists
Number of subjects: 45

Group type: COMPARATOR
Intervention: Examination by gynaecologists
Number of subjects: 45
Study: 18083473

Group type: EXPERIMENTAL
Intervention: Preoperative intravenous (IV) 50 mg flurbiprofen (group F)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Not receiving flurbiprofen (group C)
Number of subjects: 25
Study: 16216607

Group type: EXPERIMENTAL
Intervention: Magnetocardiography (MCG) at 40 Hz
Number of subjects: 19

Group type: COMPARATOR
Intervention: Signal-averaged ECG (SAECG)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Magnetocardiography (MCG) for root mean square of the last 40 milliseconds of atrial signal
Number of subjects: 19

Group type: COMPARATOR
Intervention: Signal-averaged ECG (SAECG) for root mean square of the last 40 milliseconds of atrial signal
Number of subjects: 19
Study: 12374716

Group type: EXPERIMENTAL
Intervention: LMA‐ProSeal (LMA‐PS)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Endotracheal tube (ETT)
Number of subjects: 109
Study: 9926950

Group type: EXPERIMENTAL
Intervention: midvastus approach
Number of subjects: 24

Group type: COMPARATOR
Intervention: standard parapatellar approach
Number of subjects: 24
Study: 7755058

Group type: EXPERIMENTAL
Intervention: Umbilical arteries of babies born to smoking mothers
Number of subjects: 27

Group type: COMPARATOR
Intervention: Umbilical arteries of babies born to nonsmoking mothers
Number of subjects: 27
Study: 2087438

Group type: EXPERIMENTAL
Intervention: Bradykinin (0.5 nmol)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 5-hydroxytryptamine (0.5 nmol)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Mixture of bradykinin and 5-hydroxytryptamine (0.25 nmol + 0.25 nmol)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Physiological saline
Number of subjects: 19
Study: 7124315

Group type: EXPERIMENTAL
Intervention: Ornipressin
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Adrenaline
Number of subjects: 30
Study: 31720788

Group type: EXPERIMENTAL
Intervention: Catheter ablation by pulmonary vein isolation (PVI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High-power short-duration ablation (HPSD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard ablation techniques
Number of subjects: 0
Study: 29518425

Group type: EXPERIMENTAL
Intervention: Montelukast (20 mg twice daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: LTE4 inhalation
Number of subjects: 16
Study: 26574567

Group type: EXPERIMENTAL
Intervention: Counseling regarding lifestyle behaviors (diet, weight loss, exercise)
Number of subjects: 388
Study: 24281911

Group type: EXPERIMENTAL
Intervention: 6.4% carbohydrate/electrolyte sports drink ingested 30 minutes before exercise (C30)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Flavor-matched placebo administered 30 minutes before exercise (P30)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Flavor-matched placebo administered 120 minutes before exercise (P120)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 6.4% carbohydrate/electrolyte sports drink ingested 120 minutes before exercise (C120)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 2% carbohydrate solution ingested 30 minutes before exercise
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 0% carbohydrate solution ingested 30 minutes before exercise
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: 12% carbohydrate solution ingested 30 minutes before exercise
Number of subjects: 27
Study: 22990680

Group type: EXPERIMENTAL
Intervention: Structured transfer group (written and verbal sign-outs)
Number of subjects: 32
Study: 21114950

Group type: EXPERIMENTAL
Intervention: Citalopram treatment
Number of subjects: 2280

Group type: EXPERIMENTAL
Intervention: Symptom change from baseline to week 2
Number of subjects: 2280

Group type: EXPERIMENTAL
Intervention: Recursive subsetting algorithm using baseline features and symptom change
Number of subjects: 2280
Study: 18768007

Group type: EXPERIMENTAL
Intervention: 8-week community-based relapse prevention (RP) programme
Number of subjects: 20

Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 20
Study: 15839797

Group type: EXPERIMENTAL
Intervention: 25 mg cortisol
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 12887481

Group type: EXPERIMENTAL
Intervention: 320 mg S. repens extract
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (paraffin oil)
Number of subjects: 100
Study: 10485422

Group type: EXPERIMENTAL
Intervention: Heparin-bonded (Carmeda) circuits
Number of subjects: 210

Group type: COMPARATOR
Intervention: Non-bonded circuits
Number of subjects: 210
Study: 7815572

Group type: EXPERIMENTAL
Intervention: Pediatric kidneys
Number of subjects: 183

Group type: COMPARATOR
Intervention: Adult kidneys
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 183
Study: 1938849

Group type: EXPERIMENTAL
Intervention: Verapamil 40 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Verapamil 80 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine 15 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam 5 mg
Number of subjects: 0
Study: 7007061

Group type: EXPERIMENTAL
Intervention: Folic acid
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31923193

Group type: EXPERIMENTAL
Intervention: Oral misoprostol (50 ?g every four hours as needed)
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Low dose vaginal misoprostol (25 to 50 ?g every six hours as needed)
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Vaginal dinoprostone (one to two mg every six hours as needed)
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Low dose vaginal misoprostol
Number of subjects: 511

Group type: EXPERIMENTAL
Intervention: Vaginal dinoprostone
Number of subjects: 511
Study: 31085679

Group type: EXPERIMENTAL
Intervention: Nicotinamide (NAM) 750 mg twice daily plus Lanthanum Carbonate (LC) 1000 mg thrice daily
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Nicotinamide (NAM) plus LC placebo
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Lanthanum Carbonate (LC) plus NAM placebo
Number of subjects: 205

Group type: COMPARATOR
Intervention: Double placebo
Number of subjects: 205
Study: 29281192

Group type: EXPERIMENTAL
Intervention: Dried salted plum consumption during HBO₂ therapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no dried salted plum)
Number of subjects: 90
Study: 26350942

Group type: COMPARATOR
Intervention: Alternating arm motion no WBV (Alt_NoWBV)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Alternating arm motion 30 Hz low amplitude WBV (Alt_30 Hz-L)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Alternating arm motion 50 Hz high amplitude WBV (Alt_50 Hz-H)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Double arm motion no WBV (Double_NoWBV)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Double arm motion 30Hz low amplitude WBV (Double_30Hz-L)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Double arm motion 50 Hz high amplitude WBV (Double_50 Hz-H)
Number of subjects: 28
Study: 25398689

Group type: EXPERIMENTAL
Intervention: Abediterol 0.313 μg
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Abediterol 0.625 μg
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Abediterol 1.25 μg
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Abediterol 2.5 μg
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: All doses of Abediterol
Number of subjects: 62
Study: 22260858

Group type: EXPERIMENTAL
Intervention: Doenjang (9.9 g/d for 12 weeks)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 19685958

Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo consumption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alcohol consumption (post-intoxication)
Number of subjects: 0
Study: 17927645

Group type: EXPERIMENTAL
Intervention: Telephone-administered behavioral migraine management program (TAT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard Triptan Treatment (TT)
Number of subjects: 34
Study: 15375787

Group type: EXPERIMENTAL
Intervention: 20 mg/d Wheat germ policosanol (WGP) for 4 weeks
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (control) for 4 weeks
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Wheat germ policosanol (WGP)
Number of subjects: 58
Study: 11493041

Group type: EXPERIMENTAL
Intervention: Multifaceted preventive nutrition intervention (mailed dietary recommendations, verbal endorsement by primary care provider, two motivational counseling sessions)
Number of subjects: 504

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: Multifaceted preventive nutrition intervention
Number of subjects: 504
Study: 9733054

Group type: EXPERIMENTAL
Intervention: rhIL-2, 9000000 IU subcutaneously twice daily for 3 days before surgery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no rhIL-2 administration)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: rhIL-2 group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 7984740

Group type: EXPERIMENTAL
Intervention: In-home therapy program (6 weeks)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Traditional county services (no in-home therapy)
Number of subjects: 76
Study: 2725163

Group type: EXPERIMENTAL
Intervention: Systemic treatment (antimicrobial chemotherapeutic agents)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Ototopical treatment (nonallergenic disinfectants)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Azactam (systemic treatment)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Sulfamethoxazole plus trimethoprim (systemic treatment)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (systemic treatment)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin plus metronidazole (systemic treatment)
Number of subjects: 119
Study: 786170

Group type: EXPERIMENTAL
Intervention: 0.3% tretinoin followed by a potent corticosteroid ointment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroid ointment alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tretinoin alone
Number of subjects: 0
Study: 31953834

Group type: EXPERIMENTAL
Intervention: Turkish art music
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Western classical music
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Patient's preferred music type
Number of subjects: 150

Group type: COMPARATOR
Intervention: No music (Group 2)
Number of subjects: 150

Group type: COMPARATOR
Intervention: No music (Group 1)
Number of subjects: 150
Study: 31075722

Group type: EXPERIMENTAL
Intervention: Tandospirone + escitalopram
Number of subjects: 100

Group type: COMPARATOR
Intervention: Escitalopram
Number of subjects: 100
Study: 27702846

Group type: EXPERIMENTAL
Intervention: Fluoxetine (10-40 mg daily)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 25300198

Group type: EXPERIMENTAL
Intervention: Cryoanalgesia (intercostal nerve cryoanalgesia)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Parecoxib
Number of subjects: 178
Study: 22669936

Group type: EXPERIMENTAL
Intervention: Family therapy in the context of palliative care
Number of subjects: 17
Study: 22041483

Group type: EXPERIMENTAL
Intervention: Timolol eye drops administered topically twice per day from the second week through the end of the first month.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no timolol treatment).
Number of subjects: 60
Study: 18845976

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) with passive stretching (frequency = 26 Hz) for five 1-min bouts
Number of subjects: 20

Group type: COMPARATOR
Intervention: Nonvibration treatment with passive stretching for five 1-min bouts
Number of subjects: 20
Study: 16398892

Group type: EXPERIMENTAL
Intervention: 3-SET
Number of subjects: 28

Group type: COMPARATOR
Intervention: 1-SET
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 1-SET and 3-SET
Number of subjects: 28
Study: 14660727

Group type: EXPERIMENTAL
Intervention: (90)Y-DOTA-epratuzumab at 0.370 GBq/m(2) for group 1 and 0.185 GBq/m(2) for group 2
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: (90)Y-DOTA-epratuzumab
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: (111)In-DOTA-epratuzumab
Number of subjects: 165
Study: 10651782

Group type: EXPERIMENTAL
Intervention: Azelastine 4 mg (oral) once daily for 7 days
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 12013487

Group type: EXPERIMENTAL
Intervention: Trandolapril 2 mg once daily in the morning for 4 weeks
Number of subjects: 590
Study: 1538580

Group type: EXPERIMENTAL
Intervention: Taurine (3 g/day)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Coenzyme Q10 (30 mg/day)
Number of subjects: 17
Study: 6380724

Group type: EXPERIMENTAL
Intervention: Lormetazepam 1 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Lormetazepam 2 mg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Flurazepam 30 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 30554276

Group type: EXPERIMENTAL
Intervention: Home-based physical activity intervention using Polar A360® activity trackers
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Home-based physical activity intervention
Number of subjects: 22
Study: 29351965

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 212
Study: 29469258

Group type: EXPERIMENTAL
Intervention: Study group (women with poor pregnant outcomes)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Control group (women with normal pregnancy)
Number of subjects: 217
Study: 24227120

Group type: EXPERIMENTAL
Intervention: Whole body vibration plus hypocaloric diet (WBV group)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Diet alone (CON group)
Number of subjects: 34
Study: 22804943

Group type: COMPARATOR
Intervention: Traditional multimodality therapy (gastrolavage, catharsis, methylthioninium chloride, vitamin C, symptomatic treatment)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Traditional multimodality therapy plus scopolamine
Number of subjects: 72
Study: 19789153

Group type: EXPERIMENTAL
Intervention: Colesevelam hydrochloride, 3.75 g daily
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Rosiglitazone maleate, 4 mg daily
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Sitagliptin phosphate, 100 mg daily
Number of subjects: 169
Study: 17983363

Group type: EXPERIMENTAL
Intervention: 45 degrees raised head of bed (treatment group)
Number of subjects: 30

Group type: COMPARATOR
Intervention: 25 degrees raised head of bed (control group)
Number of subjects: 30
Study: 12946091

Group type: EXPERIMENTAL
Intervention: evidence-based consumer guide to treatments for depression
Number of subjects: 1094

Group type: COMPARATOR
Intervention: general brochure on depression
Number of subjects: 1094
Study: 10881816

Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.6 mg/kg
Number of subjects: 235

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study: 9197291

Group type: EXPERIMENTAL
Intervention: Low-flow sevoflurane anesthesia (1 l/min)
Number of subjects: 48

Group type: COMPARATOR
Intervention: High-flow sevoflurane anesthesia (6-10 l/min)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Low-flow isoflurane anesthesia (1 l/min)
Number of subjects: 48
Study: 7951525

Group type: EXPERIMENTAL
Intervention: MCI‐028 (synthetic human corticotropin-releasing hormone) at doses of 33, 100, and 200 micrograms
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: MCI‐028 (synthetic human corticotropin-releasing hormone)
Number of subjects: 8
Study: 3082506

Group type: EXPERIMENTAL
Intervention: Monochemotherapy (thiotepa, six courses, 200 mg each course)
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Polychotherapy (thiotepa, methotrexate, 5‐fluorouracil [TMF], cyclophosphamide, methotrexate, 5‐fluorouracil [CMF], six courses)
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Adjuvant polychemotherapy (TMF, CMF schemes)
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Adjuvant mono- and polychemotherapy
Number of subjects: 1228

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy
Number of subjects: 1228
Study: 30085948

Group type: EXPERIMENTAL
Intervention: 10-minute 3D CAIPIRINHA SPACE TSE MRI
Number of subjects: 150

Group type: COMPARATOR
Intervention: 20-minute standard-of-reference 2D TSE MRI
Number of subjects: 150
Study: 27648854

Group type: COMPARATOR
Intervention: Unpaid Training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paid Training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Contingent Paid Training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heavy drinking days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drinks per drinking day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Days of alcohol abstinence
Number of subjects: 0
Study: 24850114

Group type: COMPARATOR
Intervention: Local anesthetic alone (Group I)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Local anesthetic with steroids (Group II)
Number of subjects: 110
Study: 22414822

Group type: EXPERIMENTAL
Intervention: Buccal infiltration with 4% articaine with epinephrine
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Intraosseous injection with 2% lidocaine with epinephrine
Number of subjects: 182

Group type: COMPARATOR
Intervention: Repeat inferior alveolar nerve block (rIANB) with 2% lidocaine with epinephrine
Number of subjects: 182

Group type: COMPARATOR
Intervention: Intraligamentary injection (PDL) with 2% lidocaine with epinephrine
Number of subjects: 182
Study: 20484066

Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (IP)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 22